Intraoperative complications of perfluoroperhydrophenanthrene: Subretinal perfluorocarbon, retinal slippage and residual perfluorocarbon

Canadian Journal of Ophthalmology

Volumn 34, Issue 5, 1999, Pages 272-280

  Meffert, Stephen ^a   Peyman, Gholam A ^a  

^a LSU EYE CENTER   (United States)

Author keywords

Intraoperative complications; Perfluorocarbon liquid; Perfluoroperhydrophenanthrene; Vitreoretinal surgery

Indexed keywords

PERFLUOROPHENANTHRENE;

ADOLESCENT; AGED; ARTICLE; CHILD; CHOROID DETACHMENT; CHOROID MELANOMA; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; LENS LUXATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; RETINA DETACHMENT; RETINA DETACHMENT SURGERY; RETINA INJURY; RETINA NEOVASCULARIZATION; RETINA TEAR; SCHOOL CHILD; VITREORETINOPATHY;

EID: 0032716191     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Haidt SJ, Clark LC, Ginsberg J. Liquid perfluorocarbon replacement of the eye [abstract]. Invest Ophthalmol Vis Sci 1982;22(suppl):233.
2. Nabih M, Peyman GA, Clark LC Jr, Hoffman RE, Miceli M, Abou-Steit M, et al. Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: a preliminary report. Ophthalmic Surg 1989;20: 286-93.
3. Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol 1987;103:38-43.
4. Blinder KJ, Peyman GA, Paris CL, Dailey JP, Alturki W, Liu KR, et al. Vitreon®, a new perfluorocarbon. Br J Ophthalmol 1991;75:240-4.
5. Chang S, Lincoff H, Zimmerman NJ, Fuchs W. Giant retinal tears: surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol 1989;107:761-6.
6. Glaser BM, Carter JB, Kuppermann BD, Michels RG. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology 1991;98: 1613-21.
7. Bottoni F, Bailo G, Arpa P, Prussiani A, Monticelli M, de Molfetta V. Management of giant retinal tears using perfluorodecalin as a postoperative short-term vitreoretinal tamponade: a long-term follow-up study. Ophthalmic Surg 1994;25:365-73.
8. Mathis A, Pagot V, Gazagne C, Malecaze F. Giant retinal tears: surgical techniques and results using perfluorodecalin and silicone oil tamponade. Retina 1992;12(3 suppl):S7-10.
9. Millsap CM, Peyman GA, Mehta NJ, Greve MDJ, Lee KJ, Ma PE, et al. Perfluoroperhydrophenanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study. Ophthalmic Surg 1993;24:759-63.
10. Kreiger AE, Lewis H. Management of giant retinal tears without scierai buckling: use of radical dissection of the vitreous base and perfluoro-octane and intraocular tamponade. Ophthalmology 1992;99:491-7.
11. Liu KR, Peyman GA, Chen MS, Chang KB. Use of high-density vitreous substitutes in the removal of posteriorly dislocated lenses or intraocular lenses. Ophthalmic Surg 1991;22:503-7.
12. Rowson NJ, Bacon AS, Rosen PH. Perfluorocarbon heavy liquids in the management of posterior dislocation of the lens nucleus during phakoemulsification. Br J Ophthalmol 1992;76:169-70.
13. Shapiro MJ, Resnick KI, Kim SH, Weinberg A. Management of the dislocated crystalline lens with a perfluorocarbon liquid. Am J Ophthalmol 1991;112:401-5.
14. Fanous MM, Friedman SM. Ciliary sulcus fixation of a dislocated posterior chamber intraocular lens using liquid perfluorophenanthrene. Ophthalmic Surg 1992;23: 551-2.
15. Greve MDJ, Peyman GA, Mehta NJ, Millsap CM. Use of perfluoroperhydrophenanthrene in the management of posteriorly dislocated crystalline and intraocular lenses. Ophthalmic Surg 1993;24:593-97.
16. Chang S, Ozmert E, Zimmerman NJ. Intraoperative perfluorocarbon liquids in the management of proliferative vitreoretinopathy. Am J Ophthalmol 1988;106:668-74.
17. Tanji TM, Peyman GA, Mehta NJ, Millsap CM. Perfluoroperhydrophenanthrene (Vitreon®) as a short-term vitreous substitute after complex vitreoretinal surgery. Ophthalmic Surg 1993;24:681-5.
18. Lee KJ, Peyman GA, Paris CL, Alturki WA, Desai UR. Management of retinal detachment associated with choroidal coloboma using perfluoroperhydrophenanthrene (Vitreon®). Ophthalmic Surg 1992;23:553-4.
19. Paris CL, Peyman GA, Blinder KJ, Alturki W, Dailey JP, Barron BA. Surgical technique for managing rhegmatogenous retinal detachment following prosthokeratoplasty. Retina 1991;11:301-4.
20. Chang S, Reppucci V, Zimmerman NJ, Heinemann MH, Coleman DJ. Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology 1989;96: 785-92.
21. Millsap CM, Peyman GA, Ma PE, Greve MDJ. The surgical management of retinopathy of prematurity using a perfluorocarbon liquid. Int Ophthalmol 1994;18:97-100.
22. Han DP, Rychwalski PJ, Mieler WF, Abrams GW. Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection. Am J Ophthalmol 1994;118:24-32.
23. Desai UR, Peyman GA, Chen CJ, Nelson NC Jr, Alturki WA, Blinder KJ, et al. Use of perfluoroperhydrophenanthrene in the management of suprachoroidal hemorrhages. Ophthalmology 1992;99:1542-7.
24. Mathis A. The use of perfluorodecalin in diabetic vitrectomy. J Vitreo Retina 1992;1:28-9.
25. Corcostegui B. Use of perfluorocarbon liquid in vitrectomy for diabetic rhegmatogenous retinal detachment. J Vitreo Retina 1992;1:30-4.
26. Forlini C, Dal Fiume E, Cicognani A, D'Eliseo D. Use of PFCL in the surgical management of endophthalmitis: new indication. J Vitreo Retina 1992;1:55-63.
27. Blinder KJ, Peyman GA, Desai UR, Nelson NC Jr, Alturki W, Paris CL. Vitreon, a short-term vitreoretinal tamponade. Br J Ophthalmol 1992;76:525-8.
28. Bottoni MF, Sborgia M, Vinciguerra P, Zenoni S, De Molfetta V. Perfluorodecalin (PFD) and perfluorophenanthrene (PFP) as post-operative short-term vitreous substitutes. J Vitreo Retina 1992;1:37-41.
29. Peyman GA, Conway MD, Soike KF, Clark LC Jr. Long-term vitreous replacement in primates with intravitreal Vitreon® or Vitreon® plus silicone. Ophthalmic Surg 1991;22:657-64.
30. Kuppermann BD, Abreau R, Moreira CA Jr, Roberts JD, Pickford M, Pince KJ, et al. Perfluoropolyether as a vitreous substitute [abstract]. Invest Ophthalmol Vis Sci 1990;31(suppl):24.
31. Bryan JS, Friedman SM, Mames RN, Margo CE. Experimental vitreous replacement with perfluorotri-n-propylamine. Arch Ophthalmol 1994;112: 1098-102.
32. Flores-Aguilar M, Munguia D, Loeb E, Crapotta JA, Vuong C, Shakiba S, et al. Intraocular tolerance of perfluorooctylbromide (Perflubron). Retina 1995;15:3-13.
33. Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R. Experimental studies of tolerance to intravitreal perfluoro-N-octane liquid. Retina 1991;11:367-74.
34. Verma LK, Peyman GA, Wafapoor H, Greve MDJ, Millsap CM, Adile SL, Vitreon Collaborative Study Group. An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Ophthalmic Surg 1995;26: 29-33.
35. Adile SL, Peyman GA, Greve MDJ, Millsap CM, Verma LK, Wafapoor H, et al. Postoperative chronic pressure abnormalities in the Vitreon study. Ophthalmic Surg 1994; 25:584-9.
36. Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90:121-5.
37. Berglin L, Ren J, Algvere PV. Retinal detachment and degeneration in response to subretinal perfluorodecalin in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 1993;231: 233-7.
38. Terauchi H, Negi A, Kazama S, Okinami S, Nagata M. Electrophysiological and histological studies of the vitreous replacement with perfluorotributylamine in the rabbit eye [abstract]. Invent Ophthalmol Vis Sci 1989;30(suppl): 102.
39. De Queiroz JM, Blanks JC, Ozler SA, Alfaro V, Liggett PE. Subretinal perfluorocarbon liquids: an experimental study. Retina 1992;12(3 suppl):S33-9.